Infectious Diseases News and Research

RSS

Focusing on innovation for planetary health

The University of Bonn has once again recruited an exceptional talent: Ina Danquah has been appointed as the new Hertz-Chair "Innovation for Planetary Health" at the "University of Excellence Bonn".

17 Nov 2023

Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).

16 Nov 2023

Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood

An interview with Dr Beverley Isherwood.

16 Nov 2023

Study sheds light on specific variants responsible for rare and serious disorder

Many disorders are caused by genetic variants; to make matters worse, the genetic origin of most disorders remains unknown.

15 Nov 2023

COVID-19 pandemic slowed progress toward ending HIV epidemic in the U.S.

The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities, according to UC Francisco researchers leading the largest U.S. evaluation of the impact of the public health crisis on people with HIV.

14 Nov 2023

Researchers identify the role of iron in ocular toxoplasmosis

Researchers from Nagoya University Graduate School of Medicine have identified the role of iron in ocular toxoplasmosis (OT), a form of toxoplasmosis that causes blindness.

14 Nov 2023

Study reveals mechanisms underlying non-suppressible HIV viremia

Human immunodeficiency virus (HIV) works by entering specific immune cells and replicating inside them.

14 Nov 2023

Study provides insights into longevity of neutralizing antibodies in HIV-1 infection

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people.

14 Nov 2023

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

A new study by investigators from Mass General Brigham found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test-;a phenomenon known as virologic rebound.

13 Nov 2023

Study reveals underuse of antiviral medications in young children with influenza

Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a new study reports an underuse of the treatment.

13 Nov 2023

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract.

From ATCC 13 Nov 2023

Vitamin D supplementation may reduce future dementia risk, study suggests

Everyone knows that vitamin D is vital for healthy bones and a stronger immune system but could low levels be a major driver of Alzheimer’s and age-related cognitive decline?

13 Nov 2023

New study sheds light on the genes and nutrients that give MAIT cells their fighting power

Scientists at La Jolla Institute for Immunology (LJI) are investigating a talented type of T cell.

10 Nov 2023

Study narrows down potential causes of Long COVID brain fog and other neuropsychiatric symptoms

Neuropsychiatric symptoms of Long COVID, including brain fog, inability to concentrate, and headache, have puzzled researchers and clinicians, who are hunting for those symptoms' causes.

10 Nov 2023

Open-science drug discovery campaign yields a wealth of data on SARS-CoV-2 main protease

Although the group's work has been freely available since its inception in March 2020, the COVID Moonshot Consortium is finally formally reporting their results.

9 Nov 2023

COVID Moonshot Consortium makes major breakthrough in antiviral drug discovery

The work of the COVID Moonshot Consortium is being published in the prestigious journal Science on 10 November, revealing their discovery of a potent SARS-CoV-2 antiviral lead compound.

9 Nov 2023

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma's Bio-TCV typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.

9 Nov 2023

Study compares the immunogenicity and safety of two SARS-CoV-2 vaccines

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019. Since then, extensive efforts have been made to develop and evaluate vaccines to combat the virus.

8 Nov 2023

Study sheds new light on the variety of cellular causes of rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation that leads to pain, joint damage, and disability, which affects approximately 18 million people worldwide.

8 Nov 2023

Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Karl Klose, director of The South Texas Center for Emerging Infectious Diseases (STCEID) and the Robert J. Kleberg, Jr. and Helen C. Kleberg College of Sciences Endowed Professor, coauthored a research article with Cameron Lloyd '23, a UTSA doctoral student who graduated in August with a Ph.D. in molecular microbiology and immunology under the guidance of Klose.

7 Nov 2023

Infectious Diseases News and Research

Focusing on innovation for planetary health

Promising new cancer therapy appears to be extremely potent against tuberculosis

Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood

Study sheds light on specific variants responsible for rare and serious disorder

COVID-19 pandemic slowed progress toward ending HIV epidemic in the U.S.

Researchers identify the role of iron in ocular toxoplasmosis

Study reveals mechanisms underlying non-suppressible HIV viremia

Study provides insights into longevity of neutralizing antibodies in HIV-1 infection

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

Study reveals underuse of antiviral medications in young children with influenza

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

Vitamin D supplementation may reduce future dementia risk, study suggests

New study sheds light on the genes and nutrients that give MAIT cells their fighting power

Study narrows down potential causes of Long COVID brain fog and other neuropsychiatric symptoms

Open-science drug discovery campaign yields a wealth of data on SARS-CoV-2 main protease

COVID Moonshot Consortium makes major breakthrough in antiviral drug discovery

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

Study compares the immunogenicity and safety of two SARS-CoV-2 vaccines

Study sheds new light on the variety of cellular causes of rheumatoid arthritis

Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News